Objectives: Positive relation between body mass and bone mineral density (BMD) is thought to be due to weight bearing effect. However, adipose tissue derived adipokines may have important effects on bone. Obese women have decreased levels of omentin in circulation which is related with adverse metabolic events. The hypothesis was that performed in this study, we aimed to study the association of omentin levels with body composition and BMD in non-diabetic postmenopausal women. Methods: Postmenopausal women aged 40 to 70 years, scheduled for BMD testing were prospectively evaluated. Patients with known diabetes, chronic renal failure, chronic liver disease, malabsorption, inflammatory bowel disease, <40 and >70 years of age were excluded. BMD and body composition were measured by DXA (GE-Lunar DPX pro). Fasting blood samples were obtained for analysis of complete blood count, glucose, creatinine, lipid profile and omentin. Statistical analyses were performed by using SPSS version 18 for windows. P<0.05 was considered statistically significant. Results: Mean age of the patients in the osteoporosis group was higher than that of the control group (59.1±7.6 vs 53.3±5.7, p<0.05). Mean omentin level was higher in osteoporosis group than in osteopenia and control groups (479.7±141.6 vs 342.3±173.6 and 346.8±127.2, p<0.05). Total body fat mass, muscle mass and the T score of lumbar spine had a negative correlation with omentin levels (r=-0.252, -0.276, -0.344, p<0.05). Conclusions: Body composition does not seem to effect omentin levels. Women with a lower BMI have increased omentin levels. Higher omentin levels are associated with lower T scores at the lumbar spine.
Introduction
Osteoporosis is a progressive, systemic disease of the skeleton which is characterized by increased risk of fractures due to low bone mass and disordered micro-architecture of the bone. For many years, it has been known that there is a positive correlation between the body mass and the bone mineral density (BMD) caused by the mechanical loading of the weight bearing bones by the body weight which stimulates the osteoblast and osteocyte proliferation and differentiation (1) (2) (3) . Besides, in obese people increased insulin levels which are seen because of the insulin resistance can increase bone formation by an anabolic effect on bone (4).
Several peptides known as adipokines are secreted from the adipose tissue found in the subcutaneous and visceral areas including the bone marrow. These act in an autocrine, paracrine or endocrine way to modulate different homeostatic events in the body. Some of these, like adiponectin and leptin, were shown to have an effect on bone remodeling (5) .
Omentin is a novel adipokine which is primarily synthesized by the visceral adipose tissue. Omentin 1 is the isoform that is predominantly found in circulation. Obese people were found to have decreased levels of omentin 1 which was also reported to be associated with insulin resistance (6). Auguet and coworkers reported that decreased circulating omentin levels had a significant association with metabolic syndrome in morbidly obese women (7) . Although the associations of omentin levels with certain metabolic problems are studied many times, to our knowledge, there are very few studies on humans that have addressed the relation of omentin with the BMD (8) (9) (10) . However these studies have conflicting results about the effect of omentin on BMD.
In this study, we aimed to investigate association of omentin levels with the BMD, body fat and muscle composition in non-diabetic postmenopausal women. 
Materials and Methods

Patient selection and laboratory evaluation
Patients were selected sequentially from postmenopausal subjects that were referred to the bone mineral testing laboratory from different outpatient clinics for several indications. These indications included women≥ 65 years of age and postmenopausal women below 65 years with a clinical risk factor for fracture (previous fracture, parental history of hip fracture, current cigarette smoking, and premature menopause). Exclusion criteria included diabetes mellitus, chronic renal failure, chronic liver disease, malabsorption, inflammatory bowel disease, <40 years of age and >70 years of age. Bone mineral densities of the lumbar spine and femoral neck were evaluated by using Dual Energy X-ray Absorptiometry (DXA, GELunar DPX pro) bone densitometer. Women with a T sore of ≤-2.5 were included in the osteoporosis group and those with a T sore between -1 and -2.5 were included in the osteopenia group. Patients with higher T scores were included in the control group. Total body composition analysis was evaluated for each of the enrolled patients by measuring the total body fat mass and muscle mass separately by using DXA device.
Fasting venous blood samples were drawn from patients for the analysis of complete blood count, lipid parameters, glucose, creatinine, and omentin levels. Serum glucose, cholesterol, LDL, VLDL, HDL, triglycerides (TG) and creatinine values were analysed by using the available commercial kits. Plasma omentin levels were assessed using a specific enzyme linked immunosorbent assay kit (Bio Vendor, Brno, Czetch Republic) (11) .
Ethical Issues
This prospective study was approved by the local ethics committee of University Medical Faculty. Written informed consents were taken from all of the enrolled subjects.
Statistical analysis
Statistical analyses were performed by the authors by using SPSS version 18 for Windows. The normality of distribution of the numerical data was evaluated by the Shapiro-Wilk test. Descriptive statistics were calculated for all variables. Comparison of the baseline characteristics, physical and laboratory parameters were performed by using analysis of variance (ANOVA) followed by posthoc Tukey test for continuous variables and chi-square test for the categorical variables. Kruskal-Wallis test was used for the comparison of non-parametric values, and for significant differences, post hoc paired comparisons were made with the Mann-Whitney test by adjusting the p value with the Bonferroni method. Receiver operating characteristics (ROC) curve was constructed to evaluate the diagnostic performance of omentin levels for osteoporosis. Optimal cut-off value and the sensitivity and specificity rates corresponding to this cut off value was calculated. Pearson or Spearman test was used to calculate the correlation coefficients and their significance for parameters that were and were not normally distributed, respectively. P<0.05 was considered statistically significant.
Results
A total of 87 patients were enrolled in this study [osteoporosis group (n=24), osteopenia group (n=23) and control group (n=20)]. Comparison of the demographic, physical and laboratory values of the patients in the three groups are demonstrated with their corresponding p values ( Table 1) . Comparison of the 3 groups showed a significant difference between the groups in terms of age, omentin levels, waist circumference, body mass index, total body fat mass and percentage, muscle mass, lumbar T score and hip T score. Pairwise posthoc comparisons by means of the Tukey test were performed to find out which two of the three groups actually differed significantly, and their results are summarized (Table 2) . Omentin level was significantly higher in the osteoporotic group than in the osteopenic or control groups. Osteoporotic patients were thinner and had a lower body fat mass than the control group.
Spearman analysis was performed to detect the correlations between the omentin level and different variables. The significant correlations with their corresponding correlation coefficients (R) are demonstrated (Table 3) . There was a significant negative correlation between the Lumbar T score and the omentin levels (Table 4) . (Fig. 1 ). 
Discussion
In our study, we demonstrated that higher omentin levels in non-diabetic postmenopausal women are associated with a decrease in BMD, so it is a risk factor for osteoporosis. As the total body fat mass and the muscle mass decrease as occurs in thinner women, omentin levels increase and BMD T scores decrease. Our finding is consistent with the already known facts that obese women have decreased serum omentin levels and obesity has a positive effect on BMD (1, 6).
Since our patient population included only nondiabetic women, and fasting blood glucose values were normal in both groups, our results were free of the effect of insulin resistance on bone.
Our finding that omentin levels have an inverse relation with BMD is also consistent with the results of Tohidi et al. (10) who published one of the very few studies in the literature that investigated the association between omentin levels and the BMD. Interestingly, this study found that there was a significant negative correlation between omentin levels and BMD at the lumbar spine. Omentin levels in our study also had a significant negative correlation with the T score only at the lumbar spine. Actually, there was also a negative correlation between omentin levels and femoral neck T score both in their and our study, but these could not reach statistical significance. During the process of osteoporosis, lumbar spine is the region that is mostly and initially affected. Studies show that, in patients <70 years of age BMD measurement of the lumbar spine have a greater detection for osteoporosis (12) . Less prominent BMD changes at the femur neck than the spine may be the reason of the lack of statistical correlation between these scores and the omentin levels both in our and that of Tohidi et al.'s study (10) .
The results of the initial in vitro and in vivo studies about the effect of omentin on bone were in favor of a positive effect of omentin on BMD (8, 13). Guo and his coworkers published the first study the findings of which opposed these results (9) . Their study population consisted of 26 girls with anorexia nervosa and 24 healthy girls. They found a negative correlation between omentin level and BMD. This was followed by the study of Tohidi et al. (10) performed in obese postmenopausal women who found a similar result.
Our finding strengthens this effect of omentin, so, we also agree that increased omentin levels seem to negatively effect BMD. However, further larger studies will be more beneficial to get more information about how omentin effects bone metabolism.
One of our aims in this study was to investigate the association of the omentin levels with the body composition assuming that women at the same weight with different fat/muscle weight distributions could have different omentin levels. Because, depending on the previous knowledge, as the fat mass increases as seen in the obese women, omentin should decrease. We found that both the fat mass and the muscle mass in the body affect the omentin levels in the same direction having a negative correlation with it. Therefore body composition does not seem to have an affect on the omentin levels.
From the ROC curve, we can see that omentin has a moderate predictive power for osteoporosis. The best cut-off value detected from the curve (≥389.2) ends up with sensitivity as much as 83%. It may be used as an additional biochemical marker to make a risk prediction for osteoporosis in patients under risk after confirmation of this association in further studies.
Our study has several limitations. First one is the small number of patients in each group which can affect the statistical power of the study. Secondly, the mean age of the patients in the osteoporosis group was higher. The omentin levels in the osteoporosis group were also higher, however logistic regression analysis which examines the relation between the omentin level and BMD, independent from the affect of age found a negative correlation between the two parameters.
Higher omentin levels seem to exert a negative effect on bone metabolism in contrast to its protective effect from some metabolic problems like arterial calcification metabolic syndrome, atherosclerosis and cardiovascular events (14, 15) . Previous studies proposed the use omentin as a biologic marker for metabolic syndrome due to its protective effects. Our and the previous three studies about the relation of omentin and bone necessitates that its role as a marker of BMD status may also be evaluated (8) (9) (10) 12) .
Conclusion
Body composition does not seem to effect omentin levels. Women with a lower BMI have increased omentin levels. Higher omentin levels are associated with lower T scores at the lumbar spine.
